Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
FTA
Upturn stock ratingUpturn stock rating

First Trust Large Cap Value AlphaDEX® Fund (FTA)

Upturn stock ratingUpturn stock rating
$80.1
Last Close (24-hour delay)
Profit since last BUY5.59%
upturn advisory
Consider higher Upturn Star rating
BUY since 33 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

07/01/2025: FTA (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type ETF
Historic Profit 12.22%
Avg. Invested days 47
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
ETF Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 07/01/2025

Key Highlights

Volume (30-day avg) -
Beta 0.99
52 Weeks Range 65.75 - 82.70
Updated Date 06/29/2025
52 Weeks Range 65.75 - 82.70
Updated Date 06/29/2025

ai summary icon Upturn AI SWOT

First Trust Large Cap Value AlphaDEX® Fund

ETF Overview

overview logo Overview

The First Trust Large Cap Value AlphaDEXu00ae Fund (FDA) is designed to provide investment results that correspond generally to the price and yield of an equity index called the StrataQuantu00ae Value Index. The fund focuses on large-cap U.S. value stocks selected and weighted based on fundamental growth factors.

reliability logo Reputation and Reliability

First Trust is a well-established ETF provider with a reputation for innovative and rules-based investment strategies.

reliability logo Management Expertise

First Trust has a dedicated team of investment professionals with experience in quantitative analysis and ETF management.

Investment Objective

overview logo Goal

The fund seeks investment results that correspond generally to the price and yield of the StrataQuantu00ae Value Index.

Investment Approach and Strategy

Strategy: The ETF employs a quantitative methodology, the AlphaDEXu00ae stock selection process, to identify and weight value stocks demonstrating superior growth potential.

Composition The ETF holds a diversified portfolio of large-cap U.S. value stocks.

Market Position

Market Share: FDA holds a moderate market share within the large-cap value ETF category.

Total Net Assets (AUM): 1585000000

Competitors

overview logo Key Competitors

  • VTV
  • IWD
  • IVE

Competitive Landscape

The large-cap value ETF market is highly competitive, with many well-established funds. FDA's AlphaDEXu00ae strategy provides a differentiated approach, but its higher expense ratio may be a disadvantage compared to lower-cost, passively managed competitors. Advantages include a potentially higher return due to active selection. Disadvantages are higher expenses and possibility of underperforming its benchmark index.

Financial Performance

Historical Performance: Historical performance data is readily available from financial data providers and First Trust's website and should be reviewed to understand the ETFu2019s track record. Return [3.82, 13.52, 9.97, 9.92, 10.82] % for the past 1,3,5,10 year and since inception respectively.

Benchmark Comparison: The ETF's performance should be compared to its benchmark, the StrataQuantu00ae Value Index, and other relevant large-cap value indices like the Russell 1000 Value Index to assess its relative performance.

Expense Ratio: 0.29

Liquidity

Average Trading Volume

FDA's average daily trading volume is adequate, but it may be lower compared to the more popular, passively managed large-cap value ETFs.

Bid-Ask Spread

The bid-ask spread for FDA is typically competitive but may widen during periods of market volatility.

Market Dynamics

Market Environment Factors

Economic indicators, interest rate movements, and value stock performance relative to growth stocks can impact FDA's performance.

Growth Trajectory

The growth trajectory of FDA is tied to the overall performance of the value stock market and the effectiveness of its AlphaDEXu00ae methodology. The ETF dynamically rebalances its holdings, which could impact its performance over time.

Moat and Competitive Advantages

Competitive Edge

FDA's competitive edge lies in its AlphaDEXu00ae methodology, which uses quantitative factors to identify value stocks with strong growth potential. This active selection approach differentiates it from passively managed value ETFs. The fund's focus on fundamental factors aims to improve stock selection. However, this active approach leads to a slightly higher expense ratio, requiring consistent outperformance to justify the cost.

Risk Analysis

Volatility

FDA's volatility is expected to be similar to other large-cap value ETFs, influenced by the volatility of the underlying stocks and broader market conditions.

Market Risk

FDA is subject to market risk, including the risk that its underlying holdings may decline in value due to economic, political, or company-specific factors.

Investor Profile

Ideal Investor Profile

FDA is suitable for investors seeking exposure to large-cap U.S. value stocks with the potential for enhanced returns through active selection. It is appropriate for investors who understand and accept the risks associated with quantitative investment strategies.

Market Risk

FDA is best suited for long-term investors seeking value exposure who are comfortable with a slightly higher expense ratio for a potentially higher return. Not recommended for purely passive index followers.

Summary

The First Trust Large Cap Value AlphaDEXu00ae Fund (FDA) offers exposure to large-cap U.S. value stocks selected using a quantitative AlphaDEXu00ae methodology. It differentiates itself from passively managed funds through its active stock selection and weighting process. While its expense ratio is higher, it aims to deliver enhanced returns through a fundamentally driven approach. The ETF is appropriate for investors seeking value exposure with a tolerance for moderate volatility and a preference for active management.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • First Trust Website
  • Morningstar
  • ETF.com
  • Yahoo Finance

Disclaimers:

The data and analysis provided are for informational purposes only and should not be considered investment advice. Investment decisions should be based on your own due diligence and consultation with a qualified financial advisor. Market share data is an estimate.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About First Trust Large Cap Value AlphaDEX® Fund

Exchange NASDAQ
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to select value stocks from the NASDAQ US 500 Large Cap Index TM (the base index) that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX® selection methodology.